Technology Transfer Fellowships – 1 Year Contract
Support tech transfer, IP, and commercialisation for research impact.
LifeArc brings together a network of partners to tackle specific diseases and directly funds academic and early-stage research with the aim to turn great science into greater patient impact. The LifeArc Technology Transfer division (TT) collaborates with and provides technology transfer and intellectual property services to a range of partners and clients including medical research charities worldwide, academic research institutes, universities, the Medical Research Council (MRC) and to LifeArc’s Centre for Therapeutics Discovery and Centre for Diagnostics Development.
www.lifearc.org
About Imperial Enterprise Division
Imperial College London has enterprise in its DNA. Founded in 1907, with a mission to offer the most advanced education and research, to collaborate with other organisations, and to apply its work to industry, today it is one of the world’s top ten universities with a thriving entrepreneurial ecosystem.
The Imperial Enterprise Division:
• Helps businesses access the College’s resources, talent and expertise to address business and societal challenges
• Supports and encourages student entrepreneurship
• Helps academics find new ways to turn their expertise and research into benefits for society
http://www.imperial.ac.uk/enterprise
About Queen Mary Innovation Ltd
Queen Mary Innovation Ltd (QMI) is Queen Mary University of London’s (QMUL) wholly-owned technology transfer company and responsible for the commercialisation and management of the University’s intellectual property and portfolio of spinout companies. QMI protects and exploits QMUL’s research-derived intellectual property and helps to maximise the economic and societal impact of that research.
http://www.qminnovation.co.uk/
About UCLB
UCLB is the commercialisation company of UCL, one of the world’s leading universities. UCLB has a strong reputation for identifying and protecting promising new technologies and innovations from the UCL research base and partner NHS Trusts; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market. UCLB’s track record of success includes over £1.5 billion raised in investment for UCL spinouts.
A bit about the role:
The translation of academic research discoveries into impactful diagnostics and treatments involves the collaboration of many innovation ecosystem stakeholders, and the use of many skills. Technology transfer professionals are key to the progress along their development pathways and, potentially, be translated into new treatments for patients. In support of this mission, LifeArc has launched a Technology Transfer Training Fellowship programme in partnership with Imperial Enterprise Division, Queen Mary Innovation and UCL Business. This initiative first launched in 2018 and aims to provide the first steps for talented scientists to transition into the technology transfer profession by providing successful fellowship applicants with training and experience in four of London’s leading technology transfer environments.
There will be four Fellows appointed who will each be given extensive training and experience in relation to identification of intellectual property (IP) with commercial potential, procuring IP protections, marketing and commercialisation processes including the eventual partnering of successful projects with the pharma industry via licensing or spin-out creation.
Each of the four participating organisations will host the Fellows, on a three-month rotational basis. Fellows will receive training on distinct topics during each rotation and benefit from being exposed to a variety of projects, expertise and organisational practises along the way.
About you:
The requirements for the successful candidates for these entry-level roles are:
Essential
• Postgraduate degree in life or medical sciences and/or MBA or equivalent
• Aptitude for describing complex scientific information in accessible terms and ability to quickly grasp new scientific concepts
• Well-developed written and oral communication skills
• Strong interpersonal skills with an ability to communicate confidently and effectively with academic staff, all levels of management and companies.
• Competence in Word, Excel, PowerPoint and Outlook
Desirable
• Experience in technology market research, analysis and reporting
• Experience in technology marketing, IP protection or commercial negotiation including contract development/analysis
• Understanding of the drug discovery process and of the academic, biotechnology and pharmaceutical industry marketplaces
What we can offer you
Because we understand everyone has different requirements, our flexible benefits allow you to choose those which are important to you. Our pension scheme offers employer contributions of up to 12%, private health insurance, and annual leave of 31 days PLUS bank holidays.
Join us, and you’ll have the scope to be creative and take measured risks. You’ll be rewarded for your curiosity, for working as one team, and for learning fast. And you’ll have everything you need to be your best every day.
We all have potential. At LifeArc, you’ll discover what you can really do with it.
LifeArc brings together a network of partners to tackle specific diseases and directly funds academic and early-stage research with the aim to turn great science into greater patient impact. The LifeArc Technology Transfer division (TT) collaborates with and provides technology transfer and intellectual property services to a range of partners and clients including medical research charities worldwide, academic research institutes, universities, the Medical Research Council (MRC) and to LifeArc’s Centre for Therapeutics Discovery and Centre for Diagnostics Development.
www.lifearc.org
About Imperial Enterprise Division
Imperial College London has enterprise in its DNA. Founded in 1907, with a mission to offer the most advanced education and research, to collaborate with other organisations, and to apply its work to industry, today it is one of the world’s top ten universities with a thriving entrepreneurial ecosystem.
The Imperial Enterprise Division:
• Helps businesses access the College’s resources, talent and expertise to address business and societal challenges
• Supports and encourages student entrepreneurship
• Helps academics find new ways to turn their expertise and research into benefits for society
http://www.imperial.ac.uk/enterprise
About Queen Mary Innovation Ltd
Queen Mary Innovation Ltd (QMI) is Queen Mary University of London’s (QMUL) wholly-owned technology transfer company and responsible for the commercialisation and management of the University’s intellectual property and portfolio of spinout companies. QMI protects and exploits QMUL’s research-derived intellectual property and helps to maximise the economic and societal impact of that research.
http://www.qminnovation.co.uk/
About UCLB
UCLB is the commercialisation company of UCL, one of the world’s leading universities. UCLB has a strong reputation for identifying and protecting promising new technologies and innovations from the UCL research base and partner NHS Trusts; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market. UCLB’s track record of success includes over £1.5 billion raised in investment for UCL spinouts.
www.uclb.com